Naltrexone Accord (Naltrexone Hydrochloride)

Naltrexone Hydrochloride, the active ingredient in Naltrexone Accord, is an opioid antagonist presented as an oral formulation for oral use. It is employed in the management of alcohol dependence and opioid dependence, helping to reduce cravings and block the reinforcing effects of these substances in adult patients under medical supervision.

GNH USA supplies Naltrexone Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets.

Naltrexone acts on the opioid system and is indicated for conditions related to alcohol and opioid use.

- Alcohol dependence: reduces cravings and risk of relapse in patients with alcohol use disorder. - Opioid dependence: blocks opioid receptors to prevent euphoria and supports detoxification in opioid use disorder. - Alcohol use disorder: assists in maintaining long‑term abstinence.

Naltrexone may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Nausea - Headache - Dizziness - Fatigue - Insomnia

Serious or Rare Side Effects: - Hepatotoxicity (elevated liver enzymes or liver injury) - Severe allergic reactions, including anaphylaxis - Depression or emergence of suicidal thoughts

Before initiating therapy with Naltrexone, several precautions should be considered. - Liver function assessment: evaluate hepatic enzymes prior to treatment. - Contraindication in acute hepatitis: avoid use in patients with active liver disease. - Monitor for depression: observe patients for mood changes or suicidal ideation. - Caution in renal impairment: adjust if severe renal dysfunction is present. - Pregnancy and breastfeeding: safety not established; weigh risks and benefits. - Store at ambient temperature: keep in original packaging, protect from moisture.

Naltrexone can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Opioid agonists (e.g., morphine, heroin): can precipitate acute withdrawal. - Hepatotoxic drugs (e.g., isoniazid, high‑dose acetaminophen): increase risk of liver injury. - Disulfiram: combined use may heighten hepatotoxic potential.

Moderate Interactions (Monitor Closely): - Alcohol: concurrent use may worsen liver function. - Antidepressants (e.g., SSRIs): monitor for mood changes. - Benzodiazepines: may increase sedation. - Methadone or buprenorphine: dose adjustments may be required.